Home
Edward J. Dulac III, CFO: Fate Therapeutics FATE Sell · Filed 23/08/21
Trade details
- Type
- Insider sale
- Amount
- $13,210.4
- Shares · price
- 4,718 sh · $2.80 a share
- Held after
- 119,570 sh
- Person
- Edward J. Dulac IIICFO
- Trade date
- 23/08/18
- Filed
- 23/08/21
- Days to filing
- 3 days
Sold 3.8% of holdings
- Share of holding sold
- 3.8%
Fate Therapeutics trades, last 26 weeks
What else happened in Fate Therapeutics around then
Filed or reported within 30 days of the trade day · 23/07/19~23/09/17Edward J. Dulac III's recent trades
- Edward J. Dulac III
Planned sale10b5-1 planIntellia Therapeutics
Planned sale10b5-1 planIntellia Therapeutics
NTLA
$80.6K
4,677 sh
$80.6K
Filed 07/02
Traded 07/02
- Edward J. Dulac III
SellIntellia Therapeutics
SellIntellia Therapeutics
NTLA
$58.8K
6,379 sh
$58.8K
Filed 01/07
Traded 01/05
- Edward J. Dulac III
SellIntellia Therapeutics
SellIntellia Therapeutics
NTLA
$104.6K
7,462 sh
$104.6K
Filed 25/07/25
Traded 25/07/23
- Edward J. Dulac III
Sell10b5-1 planFate Therapeutics
Sell10b5-1 planFate Therapeutics
FATE
$19K
2,447 sh
$19K
Filed 24/03/05
Traded 24/03/04
- Edward J. Dulac III
Sell10b5-1 planFate Therapeutics
Sell10b5-1 planFate Therapeutics
FATE
$9,245
1,849 sh
$9,245
Filed 24/01/30
Traded 24/01/29
